PandemieGrippaleV1, Ncbi, Merge, bibRecord, 000664

Influenza vaccination and the elderly: pandemic preparedness.

Identifieur interne : 000664 ( Ncbi/Merge ); précédent : 000663; suivant : 000665

Influenza vaccination and the elderly: pandemic preparedness.

Auteurs : Mary Jo Kasten [États-Unis] ; Gregory A. Poland

Source :

Drugs & aging [ 1170-229X ] ; 2008.

RBID : pubmed:18331070

Descripteurs français

KwdFr :
- Flambées de maladies (), Grippe humaine (), Grippe humaine (transmission), Grippe humaine (épidémiologie), Humains, Planification des mesures d'urgence en cas de catastrophe (), Sous-type H5N1 du virus de la grippe A (immunologie), Sujet âgé, Vaccination de masse (), Vaccins antigrippaux (administration et posologie), Vaccins antigrippaux (immunologie), États-Unis d'Amérique.
MESH :
- administration et posologie : Vaccins antigrippaux.
- immunologie : Sous-type H5N1 du virus de la grippe A, Vaccins antigrippaux.
- épidémiologie : Grippe humaine.
- Flambées de maladies, Grippe humaine, Humains, Planification des mesures d'urgence en cas de catastrophe, Sujet âgé, Vaccination de masse, États-Unis d'Amérique.
Wicri :
- geographic : États-Unis.

English descriptors

KwdEn :
- Aged, Disaster Planning (methods), Disease Outbreaks (prevention & control), Humans, Influenza A Virus, H5N1 Subtype (immunology), Influenza Vaccines (administration & dosage), Influenza Vaccines (immunology), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Influenza, Human (transmission), Mass Vaccination (methods), United States.
MESH :
- chemical , administration & dosage : Influenza Vaccines.
- geographic : United States.
- epidemiology : Influenza, Human.
- immunology : Influenza A Virus, H5N1 Subtype, Influenza Vaccines.
- methods : Disaster Planning, Mass Vaccination.
- prevention & control : Disease Outbreaks, Influenza, Human.
- transmission : Influenza, Human.
- Aged, Humans.

Abstract

Seasonal influenza causes significant morbidity and mortality in the elderly, the very young and those with chronic illness, despite the availability of effective vaccines. The mortality and morbidity attributed annually to seasonal influenza are small in comparison to the potential mortality and morbidity of a novel highly pathogenic human influenza A virus strain. The current influenza A/H5N1 virus that has caused epidemics in poultry and is evolving to find new niches needs only to become more efficiently transmitted from human to human to cause the next pandemic. Vaccination is the intervention with the potential to save the most lives when a pandemic occurs. Pandemic awareness and preparedness are essential to decrease the predicted chaos, death and illness arising from the next influenza pandemic.

DOI: 10.2165/00002512-200825030-00001
PubMed: 18331070

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 001995
to stream PubMed, to step Curation: 001995
to stream PubMed, to step Checkpoint: 001801

Links to Exploration step

pubmed:18331070

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Influenza vaccination and the elderly: pandemic preparedness.</title>
<author><name sortKey="Kasten, Mary Jo" sort="Kasten, Mary Jo" uniqKey="Kasten M" first="Mary Jo" last="Kasten">Mary Jo Kasten</name>
<affiliation wicri:level="1"><nlm:affiliation>Divisions of General Internal Medicine and Infectious Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota 59905, USA. mkasten@mayo.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Divisions of General Internal Medicine and Infectious Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota 59905</wicri:regionArea>
<wicri:noRegion>Minnesota 59905</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Poland, Gregory A" sort="Poland, Gregory A" uniqKey="Poland G" first="Gregory A" last="Poland">Gregory A. Poland</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2008">2008</date>
<idno type="RBID">pubmed:18331070</idno>
<idno type="pmid">18331070</idno>
<idno type="doi">10.2165/00002512-200825030-00001</idno>
<idno type="wicri:Area/PubMed/Corpus">001995</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001995</idno>
<idno type="wicri:Area/PubMed/Curation">001995</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001995</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001801</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001801</idno>
<idno type="wicri:Area/Ncbi/Merge">000664</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Influenza vaccination and the elderly: pandemic preparedness.</title>
<author><name sortKey="Kasten, Mary Jo" sort="Kasten, Mary Jo" uniqKey="Kasten M" first="Mary Jo" last="Kasten">Mary Jo Kasten</name>
<affiliation wicri:level="1"><nlm:affiliation>Divisions of General Internal Medicine and Infectious Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota 59905, USA. mkasten@mayo.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Divisions of General Internal Medicine and Infectious Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota 59905</wicri:regionArea>
<wicri:noRegion>Minnesota 59905</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Poland, Gregory A" sort="Poland, Gregory A" uniqKey="Poland G" first="Gregory A" last="Poland">Gregory A. Poland</name>
</author>
</analytic>
<series><title level="j">Drugs & aging</title>
<idno type="ISSN">1170-229X</idno>
<imprint><date when="2008" type="published">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Disaster Planning (methods)</term>
<term>Disease Outbreaks (prevention & control)</term>
<term>Humans</term>
<term>Influenza A Virus, H5N1 Subtype (immunology)</term>
<term>Influenza Vaccines (administration & dosage)</term>
<term>Influenza Vaccines (immunology)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Influenza, Human (transmission)</term>
<term>Mass Vaccination (methods)</term>
<term>United States</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Flambées de maladies ()</term>
<term>Grippe humaine ()</term>
<term>Grippe humaine (transmission)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains</term>
<term>Planification des mesures d'urgence en cas de catastrophe ()</term>
<term>Sous-type H5N1 du virus de la grippe A (immunologie)</term>
<term>Sujet âgé</term>
<term>Vaccination de masse ()</term>
<term>Vaccins antigrippaux (administration et posologie)</term>
<term>Vaccins antigrippaux (immunologie)</term>
<term>États-Unis d'Amérique</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>United States</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Sous-type H5N1 du virus de la grippe A</term>
<term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H5N1 Subtype</term>
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Disaster Planning</term>
<term>Mass Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Disease Outbreaks</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Flambées de maladies</term>
<term>Grippe humaine</term>
<term>Humains</term>
<term>Planification des mesures d'urgence en cas de catastrophe</term>
<term>Sujet âgé</term>
<term>Vaccination de masse</term>
<term>États-Unis d'Amérique</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>États-Unis</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Seasonal influenza causes significant morbidity and mortality in the elderly, the very young and those with chronic illness, despite the availability of effective vaccines. The mortality and morbidity attributed annually to seasonal influenza are small in comparison to the potential mortality and morbidity of a novel highly pathogenic human influenza A virus strain. The current influenza A/H5N1 virus that has caused epidemics in poultry and is evolving to find new niches needs only to become more efficiently transmitted from human to human to cause the next pandemic. Vaccination is the intervention with the potential to save the most lives when a pandemic occurs. Pandemic awareness and preparedness are essential to decrease the predicted chaos, death and illness arising from the next influenza pandemic.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18331070</PMID>
<DateCompleted><Year>2008</Year>
<Month>04</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1170-229X</ISSN>
<JournalIssue CitedMedium="Print"><Volume>25</Volume>
<Issue>3</Issue>
<PubDate><Year>2008</Year>
</PubDate>
</JournalIssue>
<Title>Drugs & aging</Title>
<ISOAbbreviation>Drugs Aging</ISOAbbreviation>
</Journal>
<ArticleTitle>Influenza vaccination and the elderly: pandemic preparedness.</ArticleTitle>
<Pagination><MedlinePgn>179-86</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Seasonal influenza causes significant morbidity and mortality in the elderly, the very young and those with chronic illness, despite the availability of effective vaccines. The mortality and morbidity attributed annually to seasonal influenza are small in comparison to the potential mortality and morbidity of a novel highly pathogenic human influenza A virus strain. The current influenza A/H5N1 virus that has caused epidemics in poultry and is evolving to find new niches needs only to become more efficiently transmitted from human to human to cause the next pandemic. Vaccination is the intervention with the potential to save the most lives when a pandemic occurs. Pandemic awareness and preparedness are essential to decrease the predicted chaos, death and illness arising from the next influenza pandemic.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kasten</LastName>
<ForeName>Mary Jo</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo><Affiliation>Divisions of General Internal Medicine and Infectious Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota 59905, USA. mkasten@mayo.edu</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Poland</LastName>
<ForeName>Gregory A</ForeName>
<Initials>GA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>New Zealand</Country>
<MedlineTA>Drugs Aging</MedlineTA>
<NlmUniqueID>9102074</NlmUniqueID>
<ISSNLinking>1170-229X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="Y">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004189" MajorTopicYN="N">Disaster Planning</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053124" MajorTopicYN="N">Influenza A Virus, H5N1 Subtype</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D032541" MajorTopicYN="N">Mass Vaccination</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year>
<Month>3</Month>
<Day>12</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2008</Year>
<Month>4</Month>
<Day>26</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2008</Year>
<Month>3</Month>
<Day>12</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">18331070</ArticleId>
<ArticleId IdType="pii">2531</ArticleId>
<ArticleId IdType="doi">10.2165/00002512-200825030-00001</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Circulation. 2000 Dec 19;102(25):3039-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11120692</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 1996 Jun;173(6):1467-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8648221</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Bull Hist Med. 2002 Spring;76(1):105-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11875246</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Control Hosp Epidemiol. 2000 Jul;21(7):449-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10926394</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2001 Jun 16;357(9272):1937-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11425416</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 1975 Aug;115(2):434-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">807637</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2000 Jan 8;355(9198):93-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10675165</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Control Hosp Epidemiol. 2000 Nov;21(11):730-2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11089659</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Epidemiol Rev. 1996;18(1):64-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8877331</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Microbes Infect. 2001 Jan;3(1):81-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11226857</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2006 May 8;24(19):4212-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16546308</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Morb Mortal Wkly Rep. 2005 Mar 4;54(8):196-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15744227</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2006 Nov 1;194 Suppl 2:S127-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17163385</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Recomm Rep. 2006 Jul 28;55(RR-10):1-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16874296</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2005 Mar 18;23(17-18):2251-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15755605</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2005 Jan 27;352(4):333-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15668219</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2005 Oct 1;366(9492):1165-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16198765</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2004 Dec;10(12):2189-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15663858</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2004 Dec 16;351(25):2611-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15602021</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2006 Nov 1;194 Suppl 2:S73-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17163392</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2004 Oct 7;431(7009):703-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15470432</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2006 Nov 23;355(21):2186-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17124016</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2001 Feb 8;19(13-14):1732-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11166898</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2004 Nov 25;351(22):2286-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15525713</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2006 Nov 1;194 Suppl 2:S111-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17163383</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2002 Aug 15;35(4):378-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12145719</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2005 Nov 24;353(21):2209-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16306515</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2006 Mar 30;354(13):1411-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16571885</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2007 Aug;7(8):503-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17646023</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Circulation. 2002 May 7;105(18):2143-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11994246</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2006 Mar 30;354(13):1343-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16571878</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2005 Oct 6;437(7060):889-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16208372</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2002 Mar 15;20(13-14):1831-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11906772</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2006 May 20;367(9523):1636-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16714169</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Intern Med. 1995 Oct 1;123(7):518-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7661497</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
</list>
<tree><noCountry><name sortKey="Poland, Gregory A" sort="Poland, Gregory A" uniqKey="Poland G" first="Gregory A" last="Poland">Gregory A. Poland</name>
</noCountry>
<country name="États-Unis"><noRegion><name sortKey="Kasten, Mary Jo" sort="Kasten, Mary Jo" uniqKey="Kasten M" first="Mary Jo" last="Kasten">Mary Jo Kasten</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000664 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000664 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:18331070
   |texte=   Influenza vaccination and the elderly: pandemic preparedness.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:18331070" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a PandemieGrippaleV1

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021

	Serveur d'exploration sur les pandémies grippales
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les pandémies grippales

Influenza vaccination and the elderly: pandemic preparedness.

Influenza vaccination and the elderly: pandemic preparedness.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki